Marubi(SH:603983) Great Wall Securities·2025-07-17 11:14Investment Rating - The report assigns an "Accumulate" rating for the company, indicating a positive outlook for the stock over the next six months [4]. Core Insights - The company has a well-established brand matrix based on skin science and biological science, focusing on the research, design, production, sales, and service of various cosmetics [1][9]. - The main brand, Marubi, has successfully implemented a big product strategy, particularly in eye care, maintaining the top sales position in this category for three consecutive years [2]. - The PL brand, focusing on base makeup, has achieved significant sales milestones, with multiple products exceeding 100 million yuan in annual GMV [3]. Financial Performance - The company is projected to achieve revenues of 2,226 million yuan in 2023, growing to 6,051 million yuan by 2027, with a compound annual growth rate (CAGR) of approximately 24.6% [1][10]. - The net profit attributable to shareholders is expected to rise from 259 million yuan in 2023 to 729 million yuan in 2027, reflecting a strong growth trajectory [1][10]. - The company's gross margin improved to 73.7% in 2024, up 3.01 percentage points year-on-year, driven by optimized product structure and cost control [8]. Brand Strategy - Marubi's core philosophy is centered around "focusing on reducing every fine line," which has solidified its brand identity in eye care and wrinkle reduction [2]. - The PL brand emphasizes user-friendly and high-quality products, reinforcing its market position in the base makeup category [3]. Market Position - Marubi has become a leading brand in the domestic mid-to-high-end skincare market, while PL has established itself as a strong player in the makeup segment [1][3]. - The company aims to leverage global leading technologies to develop high-quality products, guided by a long-term strategy focused on "technology-driven beauty and health" [9].